These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12678459)

  • 1. Strategies to prevent hypoglycaemia during insulin therapy in Type 2 diabetes.
    Yki-Järvinen H
    Diabetes Nutr Metab; 2002 Dec; 15(6):411-6. PubMed ID: 12678459
    [No Abstract]   [Full Text] [Related]  

  • 2. Premixed insulin regimens for type 2 diabetes.
    Tsapas A; Karagiannis T; Bekiari E
    Endocrine; 2016 Mar; 51(3):387-9. PubMed ID: 26649859
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 4. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.
    Home PD; Dain MP; Freemantle N; Kawamori R; Pfohl M; Brette S; Pilorget V; Scherbaum WA; Vespasiani G; Vincent M; Balkau B
    Diabetes Res Clin Pract; 2015 May; 108(2):350-9. PubMed ID: 25825361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starting insulin therapy in type 2 diabetes: lesson 1.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):325-6. PubMed ID: 16188164
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin regimens in type 2 diabetes.
    Lund SS; Vaag AA
    N Engl J Med; 2010 Mar; 362(10):959; author reply 960. PubMed ID: 20220196
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoglycaemia: an overview.
    Graveling AJ; Frier BM
    Prim Care Diabetes; 2009 Aug; 3(3):131-9. PubMed ID: 19782016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different strategies in prediabetes, new and long-time diabetes. What therapy for what diabetics?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jan; 152(3):12-4, 16. PubMed ID: 20333958
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HYPOGLYCEMIA IN THE ELDERLY WITH DIABETES: A GROWING PROBLEM WITH EMERGING SOLUTIONS.
    Grajower MM
    Endocr Pract; 2018 Mar; 24(3):312-314. PubMed ID: 29547043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable reversal of hypoglycemia unawareness in type 1 diabetes.
    Dagogo-Jack S; Fanelli CG; Cryer PE
    Diabetes Care; 1999 May; 22(5):866-7. PubMed ID: 10332708
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
    Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
    Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.
    Riddle MC
    Diabetes Care; 2008 Feb; 31 Suppl 2():S125-30. PubMed ID: 18227472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type 2 diabetes: hypoglycemia risk, weight gain... Will there soon be a new alternative to insulin?].
    MMW Fortschr Med; 2006 Sep; 148(37):54. PubMed ID: 17036907
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
    Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
    Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
    Krzymień J; Kobli T; Nazar M
    Pol Arch Med Wewn; 2010 Nov; 120(11):444-50. PubMed ID: 21102380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.
    Lane W; Weinrib S; Rappaport J
    Diabetes Technol Ther; 2011 May; 13(5):592-5. PubMed ID: 21406014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is avoidance of hypoglycaemia a better target than HbA1C in older people with diabetes?
    Mattishent K; Loke YK
    Br J Clin Pharmacol; 2021 Jan; 87(1):9-11. PubMed ID: 32864750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.